This is a working overview of Peptidase stability, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-12. Anything still debated is marked as such rather than presented as settled.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
| Property | Value | Notes |
|---|---|---|
| Route studied | Intranasal | Predominant route in published reports |
| Circulation stability | Short, minutes scale | Peptidases cleave it; the tail slows the process |
| Analytical method | RP-HPLC with mass spectrometry | Used for identity and purity assessment |
| Reported outcome domains | Anxiety and cognitive measures | Derived from small, mostly regional trials |
| Regulatory status | Marketed in Russia | Availability outside that market is limited |
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
Reported pharmacological effects center on reduced anxiety-like behavior in animal models and on measures of memory and learning. Proposed contributing mechanisms include modulation of GABAergic signaling, shifts in monoamine turnover, and changes in the activity of enzymes that degrade neuropeptides. Effects on the expression of genes linked to neuroplasticity have also been described. No single molecular target is widely accepted, and whether the behavioral findings arise from one pathway or several remains an open question.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
Acapulco, with its natural harbor, had been settled by indigenous peoples for thousands of years and later established as a port by Hernán Cortés in 1523. By Humboldt’s visit, the city had diminished in significance, with a small population and little commercial activity. Upon arrival, Humboldt used his instruments to correct geographic errors caused by local currents and earthquakes, further improving navigation and mapping accuracy. Humboldt’s primary reason for coming to New Spain was to secure passage to the Philippines, but he viewed Mexico as a vital subject for study. At the start of the nineteenth century, New Spain was a populous and prosperous colony, contributing significantly to Spain’s economy through silver, gold, and agricultural production. Humboldt, holding a royal passport, enjoyed unprecedented access to official records and facilities, enabling him to study the country’s economic and political structures thoroughly.
=== HIV infection === Macrophages also play a role in human immunodeficiency virus (HIV) infection. Like T cells, macrophages can be infected with HIV, and even become a reservoir of ongoing virus replication throughout the body. HIV can enter the macrophage through binding of gp120 to CD4 and second membrane receptor, CCR5 (a chemokine receptor). Both circulating monocytes and macrophages serve as a reservoir for the virus. Macrophages are better able to resist infection by HIV-1 than CD4+ T cells, although susceptibility to HIV infection differs among macrophage subtypes.
Ethylene glycol, the main ingredient in some antifreeze, is poisonous to both people and other mammals. After ethylene glycol is ingested, it is metabolized in the liver into various intermediate substances, which then get turned into oxalic acid. Oxalic acid is incredibly dangerous as it can cause, among other ailments, kidney failure, which is why a major treatment for antifreeze poisoning is kidney dialysis. Common symptoms of poisoning are vomiting, confusion, abdominal pain, agitation, ataxia and hematuria. Long term damage such as kidney damage, brain damage, central nervous system damage, and blindness are common. Antifreeze may be consumed by children and pets for its sweet taste, and is also commonly consumed as a surrogate alcohol due to its high alcohol content. Many formulations include bitter additives to discourage consumption due to taste; however, many studies do not support embittering antifreeze to reduce its ingestion.
Robbins (1963), psychiatrist, scholar on expatriate communities in India Richard Waldinger (1963), computer scientist, fellow of the Association for the Advancement of Artificial Intelligence Allan Blaer (1964), physicist and professor who is in charge of the Columbia University Science Honors Program Frederick Kantor (1964), physicist, inventor of glancing incidence X-ray telescope Richard A. Muller (1964), professor of physics at the University of California, Berkeley; winner of the MacArthur Fellowship in 1982 and the Alan T. Waterman Award in 1978; founder of climate science institute Berkeley Earth Kenneth Prager (1964), physician, professor at Columbia University Medical Center, brother of commentator Dennis Prager Mark C. Rogers (1964), physician, former CEO of Duke University Health System Michael Terman (1964), Columbia University Medical Center psychologist Norman Christ (1965), physicist, professor at Columbia University Niles Eldredge (1965), collaborator of Stephen Jay Gould and curator of the Department of Invertebrates at the American Museum of Natural History Alan I. Green (1965), professor at Geisel School of Medicine, nephew of Herman Wouk Stuart Newman (1965), developmental and evolutionary biologist Allen Steere (1965), rheumatologist and pioneering investigator of Lyme disease Sylvain Cappell (1966), mathematician, professor at the Courant Institute of Mathematical Sciences Barry S.
Sources: en.wikipedia.org
Some minor opium alkaloids and various substances with opioid action are also found elsewhere, including molecules present in kratom, Corydalis, and Salvia divinorum plants and some species of poppy aside from Papaver somniferum. There are also strains which produce copious amounts of thebaine, an important raw material for making many semi-synthetic and synthetic opioids. Of all of the more than 120 poppy species, only two produce morphine. Amongst analgesics there are a small number of agents which act on the central nervous system but not on the opioid receptor system and therefore have none of the other (narcotic) qualities of opioids although they may produce euphoria by relieving pain—a euphoria that, because of the way it is produced, does not form the basis of habituation, physical dependence, or addiction. Foremost amongst these are nefopam, orphenadrine, and perhaps phenyltoloxamine or some other antihistamines. Tricyclic antidepressants have painkilling effect as well, but they're thought to do so by indirectly activating the endogenous opioid system. Paracetamol is predominantly a centrally acting analgesic (non-narcotic) which mediates its effect by action on descending serotonergic pathways, to increase 5-HT release (which inhibits release of pain mediators). It also decreases cyclo-oxygenase activity. It has recently been discovered that most or all of the therapeutic efficacy of paracetamol is due to a metabolite, AM404, which enhances the release of serotonin and inhibits the uptake of anandamide.
== Structure and reactivity == κ-Bungarotoxin has a single polypeptide chain consisting of 66 amino acids. The overall weight of this chain is 7313 DA. Two single polypeptide chains can arrange together into a dimer. The subunit of the dimer consists of three main chain loops. These loops have a rotation of 178.6 degrees. Overall, κ-bungarotoxin has ten beta strands. This forms a six stranded antiparallel beta sheet configuration[8]. This is formed by three out of the five beta strands of each subunit of the dimer. Arg 34 is at the top of the central loop for each subunit. The outer strand of loop III is involved in an antiparallel arrangement. The κ-bungarotoxin dimer can make disulfide bonds, hydrogen bonds and van der Waals connections.
== Drying defects == Drying defects are the most common form of degrade in timber, next to natural problems such as knots. There are two types of drying defects, although some defects involve both causes:
=== Hard and soft ultraviolet === Some sources use the distinction of "hard UV" and "soft UV". For instance, in the case of astrophysics, the boundary may be at the Lyman limit (wavelength 91.2 nm, the energy needed to ionise a hydrogen atom from its ground state), with "hard UV" being more energetic; the same terms may also be used in other fields, such as cosmetology, optoelectronic, etc. The numerical values of the boundary between hard/soft, even within similar scientific fields, do not necessarily coincide; for example, one applied-physics publication used a boundary of 190 nm between hard and soft UV regions.
but that still shouldn't hurt someone taking legalized performance enhancing substances to try and absolutely RIP it out there in competition." Financial Times said the same month "A year on, with just one athlete publicly signed on to the project and no concrete plans for either a venue or a date, the project looks increasingly like a weird thought experiment, despite its high-profile backers. For D'Souza, the second Trump presidency could be what the Enhanced Games needs to get off the ground." The Times said in May 2025 "The Enhanced Games may be divisive, even dystopian to some. As far as D'Souza is concerned, they are the future — and the starting pistol is about to fire." Time listed D'Souza and Angermayer among the "Most Influential People in Health of 2025". The Economist said that the Games align with a growing human enhancement industry, aiming to improve strength, intelligence, and longevity.
Sources: en.wikipedia.org
Macrolides Azithromycin Clarithromycin Erythromycin When taken independently, erythromycin has been shown to cause both QT prolongation and TdP. Erythromycin works inhibiting the CYP3A protein. Patients who have low CYP3A activity and are also concurrently taking other medications such as disopyramide, which can lead to QT prolongation and TdP. Fluoroquinolones Ciprofloxacin Levofloxacin Moxifloxacin
=== T-boxes === These elements are bound by specific uncharged tRNAs and modulate the expression of corresponding aminoacyl-tRNA synthetase operons. High levels of uncharged tRNA promote the anti-terminator sequence leading to increased concentrations of charged tRNA. These are considered by some to be a separate family of riboswitches but are significantly more complex than the previous class of attenuators.
== Tracing of illicit drugs == Illegal heroin may be produced using poppy straw as a raw material. The alkaloid profiles of poppy straw and opium are similar, but preliminary research suggests they can be distinguished by relative quantities of alkaloids. Based on the presence of the alkaloid oripavine in some opium poppies, it has been suggested that illegal heroin seized in Australia was produced from a legal poppy straw crop stolen in Tasmania a few years earlier.
The NCI continued to commission work to collect more Taxus bark and to isolate increasing quantities of taxol. By 1969, 28 kg (62 lb) of crude extract had been isolated from almost 1,200 kg (2,600 lb) of bark, although this ultimately yielded only 10 g (0.35 oz) of pure material, but for several years, no use was made of the compound by the NCI. In 1975, it was shown to be active in another in vitro system; two years later, a new department head reviewed the data and finally recommended taxol be moved on to the next stage in the discovery process. This required increasing quantities of purified taxol, up to 600 g (21 oz), and in 1977 a further request for 7,000 lb (3,200 kg) of bark was made. In 1978, two NCI researchers published a report showing that taxol was mildly effective in leukaemic mice. In November 1978, taxol was shown to be effective in xenograft studies. Meanwhile, taxol began to be well known in the cell biology, as well as the cancer communities, with a publication in early 1979 by Susan B. Horwitz, a molecular pharmacologist at Albert Einstein College of Medicine, showing that taxol had a previously unknown mechanism of action involving the stabilization of microtubules. Together with formulation problems, this increased interest from researchers meant that, by 1980, the NCI envisaged needing to collect 20,000 lb (9,100 kg) of bark. Animal toxicology studies were completed by June 1982, and in November, the NCI applied for the IND necessary to begin clinical trials in humans.
Sources: en.wikipedia.org
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.
Intranasal delivery is the route described in most published work. It is used because the peptide is degraded quickly once it reaches circulation. Direct evidence of brain penetration in humans is lacking.
Most trials are small, regionally concentrated, and often lack rigorous blinding or placebo control. Independent replication is limited. Reviews in English generally rate the evidence as preliminary.
Purity is usually reported as an HPLC area percentage, most often measured at 214 nm. Identity is confirmed separately by mass spectrometry. A certificate of analysis should state both the method and the observed value.